Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Efficiency of Ionic Liquids-Based Aqueous Two-phase Electrophoresis for Partition of Cytochrome c.

Kee PE, Lan JC, Yim HS, Tan JS, Chow YH, Ng HS.

Appl Biochem Biotechnol. 2020 Jan 6. doi: 10.1007/s12010-019-03202-y. [Epub ahead of print]

PMID:
31907777
2.

Recent Developments of Reverse Micellar Techniques for Lysozyme, Bovine Serum Albumin, and Bromelain Extraction.

Chia SR, Tang MSY, Chow YH, Ooi CW, Rambabu K, Zhu L, Show PL.

Mol Biotechnol. 2019 Oct;61(10):715-724. doi: 10.1007/s12033-019-00200-7. Review.

PMID:
31350687
3.

Reverse Micellar System in Protein Recovery - A Review of the Latest Developments.

Sankaran R, Bong JH, Chow YH, Wong FWF, Ling TC, Show PL.

Curr Protein Pept Sci. 2019;20(10):1012-1026. doi: 10.2174/1389203720666190628142203. Review.

PMID:
31264547
4.

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.

Wu CY, Yu SL, Chen YT, Chen YH, Hsiao PW, Chow YH, Chen JR.

PLoS One. 2019 Jan 16;14(1):e0210553. doi: 10.1371/journal.pone.0210553. eCollection 2019.

5.

Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model.

Chang HW, Wu MJ, Lin ZM, Wang CY, Cheng SY, Lin YK, Chow YH, Ch'ang HJ, Chang VHS.

Front Pharmacol. 2018 Jul 24;9:778. doi: 10.3389/fphar.2018.00778. eCollection 2018.

6.

A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge.

Lin YL, Chow YH, Huang LM, Hsieh SM, Cheng PY, Hu KC, Chiang BL.

Sci Rep. 2018 Jul 16;8(1):10713. doi: 10.1038/s41598-018-28281-5.

7.

Maternal immunization with a recombinant adenovirus-expressing fusion protein protects neonatal cotton rats from respiratory syncytia virus infection by transferring antibodies via breast milk and placenta.

Shao HY, Chen YC, Chung NH, Lu YJ, Chang CK, Yu SL, Liu CC, Chow YH.

Virology. 2018 Aug;521:181-189. doi: 10.1016/j.virol.2018.06.009. Epub 2018 Jun 28.

8.

Extractive purification of recombinant thermostable lipase from fermentation broth of Escherichia coli using an aqueous polyethylene glycol impregnated resin system.

Tan JS, Abbasiliasi S, Ariff AB, Ng HS, Bakar MHA, Chow YH.

3 Biotech. 2018 Jun;8(6):288. doi: 10.1007/s13205-018-1295-y. Epub 2018 Jun 9.

9.

Author Correction: Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence.

Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, Yu SL, Liu CC, Chow YH.

Sci Rep. 2018 Jun 4;8(1):8744. doi: 10.1038/s41598-018-26833-3.

10.

Role of integrin alpha8 in murine model of lung fibrosis.

Hung CF, Wilson CL, Chow YH, Schnapp LM.

PLoS One. 2018 May 29;13(5):e0197937. doi: 10.1371/journal.pone.0197937. eCollection 2018.

11.

Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence.

Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, Yu SL, Liu CC, Chow YH.

Sci Rep. 2018 Apr 27;8(1):6688. doi: 10.1038/s41598-018-25091-7. Erratum in: Sci Rep. 2018 Jun 4;8(1):8744.

12.

Recovery of biotechnological products using aqueous two phase systems.

Phong WN, Show PL, Chow YH, Ling TC.

J Biosci Bioeng. 2018 Sep;126(3):273-281. doi: 10.1016/j.jbiosc.2018.03.005. Epub 2018 Apr 16. Review.

PMID:
29673987
13.

Direct recovery of Bacillus subtilis xylanase from fermentation broth with an alcohol/salt aqueous biphasic system.

Ng HS, Chai CXY, Chow YH, Loh WLC, Yim HS, Tan JS, Lan JC.

J Biosci Bioeng. 2018 May;125(5):585-589. doi: 10.1016/j.jbiosc.2017.12.010. Epub 2018 Jan 12.

PMID:
29339003
14.

Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.

Chang HW, Lin ZM, Wu MJ, Wang LY, Chow YH, Jiang SS, Ch'ang HJ, Chang VH.

PLoS One. 2017 Apr 18;12(4):e0175586. doi: 10.1371/journal.pone.0175586. eCollection 2017.

15.

Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.

Liu CC, Wu SC, Wu SR, Lin HY, Guo MS, Yung-Chih Hu A, Chow YH, Chiang JR, Shieh DB, Chong P.

Vaccine. 2018 May 24;36(22):3134-3139. doi: 10.1016/j.vaccine.2017.02.042. Epub 2017 Mar 6.

PMID:
28274636
16.

Ablation of Pericyte-Like Cells in Lungs by Oropharyngeal Aspiration of Diphtheria Toxin.

Hung CF, Chow YH, Liles WC, Altemeier WA, Schnapp LM.

Am J Respir Cell Mol Biol. 2017 Feb;56(2):160-167. doi: 10.1165/rcmb.2016-0083MA.

17.

Characterization of partitioning behaviors of immunoglobulin G in polymer-salt aqueous two-phase systems.

Chow YH, Yap YJ, Show PL, Juan JC, Anuar MS, Ng EP, Ooi CW, Ling TC.

J Biosci Bioeng. 2016 Nov;122(5):613-619. doi: 10.1016/j.jbiosc.2016.04.008. Epub 2016 May 24.

PMID:
27233672
18.

Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.

Yang YT, Chow YH, Hsiao KN, Hu KC, Chiang JR, Wu SC, Chong P, Liu CC.

Antiviral Res. 2016 Aug;132:225-32. doi: 10.1016/j.antiviral.2016.06.014. Epub 2016 Jul 4.

PMID:
27387826
19.

Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture.

Shao HY, Hsu HS, Yu SL, Wu SR, Hu KC, Chang CK, Liu CC, Chow YH.

Antiviral Res. 2016 Jun;130:27-35. doi: 10.1016/j.antiviral.2016.03.011. Epub 2016 Mar 19.

PMID:
27001351
20.

Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.

Liu CC, Guo MS, Wu SR, Lin HY, Yang YT, Liu WC, Chow YH, Shieh DB, Wang JR, Chong P.

Antiviral Res. 2016 May;129:58-66. doi: 10.1016/j.antiviral.2016.02.008. Epub 2016 Feb 17.

PMID:
26899790
21.

Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection.

Shao HY, Huang JY, Lin YW, Yu SL, Chitra E, Chang CK, Sung WC, Chong P, Chow YH.

Int J Infect Dis. 2015 Dec;41:56-64. doi: 10.1016/j.ijid.2015.10.026. Epub 2015 Nov 10.

22.

Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse.

Wu CY, Lin YW, Kuo CH, Liu WH, Tai HF, Pan CH, Chen YT, Hsiao PW, Chan CH, Chang CC, Liu CC, Chow YH, Chen JR.

PLoS One. 2015 Aug 19;10(8):e0136420. doi: 10.1371/journal.pone.0136420. eCollection 2015.

23.

Insulin Receptor Substrate-1 Activation Mediated p53 Downregulation Protects Against Hypoxic-Ischemia in the Neonatal Brain.

Tu YF, Jiang ST, Chow YH, Huang CC, Ho CJ, Chou YP.

Mol Neurobiol. 2016 Aug;53(6):3658-3669. doi: 10.1007/s12035-015-9300-5. Epub 2015 Jun 26.

PMID:
26111627
24.

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.

Tsou YL, Lin YW, Shao HY, Yu SL, Wu SR, Lin HY, Liu CC, Huang C, Chong P, Chow YH.

PLoS Negl Trop Dis. 2015 Apr 9;9(4):e0003692. doi: 10.1371/journal.pntd.0003692. eCollection 2015 Apr.

25.

Characterization of bovine serum albumin partitioning behaviors in polymer-salt aqueous two-phase systems.

Chow YH, Yap YJ, Tan CP, Anuar MS, Tejo BA, Show PL, Ariff AB, Ng EP, Ling TC.

J Biosci Bioeng. 2015 Jul;120(1):85-90. doi: 10.1016/j.jbiosc.2014.11.021. Epub 2014 Dec 29.

PMID:
25553974
26.

Review of enterovirus 71 vaccines.

Chong P, Liu CC, Chow YH, Chou AH, Klein M.

Clin Infect Dis. 2015 Mar 1;60(5):797-803. doi: 10.1093/cid/ciu852. Epub 2014 Oct 28. Review.

PMID:
25352588
27.

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Chiu SH, Wu CC, Fang CY, Yu SL, Hsu HY, Chow YH, Chen JY.

Oncotarget. 2014 Sep 30;5(18):8583-601.

28.

Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.

Liu CC, Chow YH, Chong P, Klein M.

Vaccine. 2014 Oct 29;32(47):6177-82. doi: 10.1016/j.vaccine.2014.08.064. Epub 2014 Sep 13. Review.

PMID:
25218294
29.

Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.

Liu CC, Hwang CS, Yang WS, Tsai DC, Wu SH, Chou AH, Chow YH, Wu SC, Wang JR, Chiang JR, Huang CC, Pan CH, Chong P.

PLoS One. 2014 Sep 8;9(9):e106756. doi: 10.1371/journal.pone.0106756. eCollection 2014.

30.

Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.

Chang YC, Chow YH, Sun HL, Liu YF, Lee YT, Lue KH, Ko JL.

Antiviral Res. 2014 Oct;110:124-31. doi: 10.1016/j.antiviral.2014.08.006. Epub 2014 Aug 14.

PMID:
25131377
31.

Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.

Lin CW, Liu CC, Lu TC, Liu SJ, Chow YH, Chong P, Huang MH.

Biomed Res Int. 2014;2014:670506. doi: 10.1155/2014/670506. Epub 2014 Jun 11.

32.

uPARAP function in cutaneous wound repair.

Rohani MG, Chow YH, Razumova MV, Ash S, Hung CF, Schnapp LM.

PLoS One. 2014 Mar 24;9(3):e92660. doi: 10.1371/journal.pone.0092660. eCollection 2014.

33.

Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.

Nguyen EV, Gharib SA, Crothers K, Chow YH, Park DR, Goodlett DR, Schnapp LM.

Am J Physiol Lung Cell Mol Physiol. 2014 Jan 1;306(1):L35-42. doi: 10.1152/ajplung.00140.2013. Epub 2013 Nov 8.

34.

Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy.

Tsou YL, Lin YW, Chang HW, Lin HY, Shao HY, Yu SL, Liu CC, Chitra E, Sia C, Chow YH.

PLoS One. 2013 Oct 2;8(10):e77133. doi: 10.1371/journal.pone.0077133. eCollection 2013.

35.

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.

Chang HW, Lin YW, Ho HM, Lin MH, Liu CC, Shao HY, Chong P, Sia C, Chow YH.

PLoS One. 2013 Jul 30;8(7):e69858. doi: 10.1371/journal.pone.0069858. Print 2013.

36.

Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis.

Hung C, Linn G, Chow YH, Kobayashi A, Mittelsteadt K, Altemeier WA, Gharib SA, Schnapp LM, Duffield JS.

Am J Respir Crit Care Med. 2013 Oct 1;188(7):820-30. doi: 10.1164/rccm.201212-2297OC.

37.

Interfacial partitioning behaviour of bovine serum albumin in polymer-salt aqueous two-phase system.

Chow YH, Yap YJ, Anuar MS, Tejo BA, Ariff A, Show PL, Ng EP, Ling TC.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 1;934:71-8. doi: 10.1016/j.jchromb.2013.06.034. Epub 2013 Jul 5.

PMID:
23911538
38.

Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection.

Lin HY, Yang YT, Yu SL, Hsiao KN, Liu CC, Sia C, Chow YH.

J Virol. 2013 Aug;87(16):9064-76. doi: 10.1128/JVI.00573-13. Epub 2013 Jun 12.

39.

Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia.

Nguyen EV, Gharib SA, Palazzo SJ, Chow YH, Goodlett DR, Schnapp LM.

PLoS One. 2013;8(3):e58782. doi: 10.1371/journal.pone.0058782. Epub 2013 Mar 7.

40.

Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.

Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, Chitra E, Tsou YL, Chang HW, Sia C, Chong P, Chow YH.

PLoS One. 2013;8(2):e57591. doi: 10.1371/journal.pone.0057591. Epub 2013 Feb 25.

41.

Immunological evaluation and comparison of different EV71 vaccine candidates.

Chou AH, Liu CC, Chang JY, Lien SP, Guo MS, Tasi HP, Hsiao KN, Liu SJ, Sia C, Wu SC, Lee MS, Hsiao CH, Wang JR, Chow YH, Chong P.

Clin Dev Immunol. 2012;2012:831282. Epub 2012 Sep 12.

42.

Production of EV71 vaccine candidates.

Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, Liu SJ, Chow YH, Su IJ, Klein M.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1775-83. doi: 10.4161/hv.21739. Epub 2012 Sep 19. Review.

43.

In vivo targeting of alveolar macrophages via RAFT-based glycopolymers.

Song EH, Manganiello MJ, Chow YH, Ghosn B, Convertine AJ, Stayton PS, Schnapp LM, Ratner DM.

Biomaterials. 2012 Oct;33(28):6889-97. doi: 10.1016/j.biomaterials.2012.06.025. Epub 2012 Jul 6.

44.

Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.

Chou AH, Liu CC, Chang CP, Guo MS, Hsieh SY, Yang WH, Chao HJ, Wu CL, Huang JL, Lee MS, Hu AY, Lin SC, Huang YY, Hu MH, Chow YH, Chiang JR, Chang JY, Chong P.

PLoS One. 2012;7(4):e34834. doi: 10.1371/journal.pone.0034834. Epub 2012 Apr 17.

45.

Effect of insulin-like growth factor blockade on hyperoxia-induced lung injury.

Kim TH, Chow YH, Gill SE, Schnapp LM.

Am J Respir Cell Mol Biol. 2012 Sep;47(3):372-8. doi: 10.1165/rcmb.2012-0085OC. Epub 2012 Apr 5.

46.

Short communication: adhesion pathways utilized by HIV-infected lymphocytes.

Chow YH, Liu L, Schwartz B, Harlan JM, Schnapp LM.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1557-60. doi: 10.1089/AID.2011.0262. Epub 2012 Apr 13.

47.

Human SCARB2-mediated entry and endocytosis of EV71.

Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH.

PLoS One. 2012;7(1):e30507. doi: 10.1371/journal.pone.0030507. Epub 2012 Jan 17.

48.

Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.

Shao HY, Lin YW, Yu SL, Lin HY, Chitra E, Chang YC, Sia C, Chong P, Hsu MT, Wei OL, Chow YH.

PLoS One. 2011;6(9):e25500. doi: 10.1371/journal.pone.0025500. Epub 2011 Sep 29.

49.

Role of urokinase plasminogen activator receptor-associated protein in mouse lung.

Bundesmann MM, Wagner TE, Chow YH, Altemeier WA, Steinbach T, Schnapp LM.

Am J Respir Cell Mol Biol. 2012 Feb;46(2):233-9. doi: 10.1165/rcmb.2010-0485OC. Epub 2011 Sep 22.

50.

Development of an electronic emergency department-based geo-information injury surveillance system in Hong Kong.

Chow CB, Leung M, Lai A, Chow YH, Chung J, Tong KM, Lit A.

Injury. 2012 Jun;43(6):739-48. doi: 10.1016/j.injury.2011.08.008. Epub 2011 Sep 15.

PMID:
21924722

Supplemental Content

Support Center